Mister-Blister > Fibrosis

Fibrosis

Email: <a href="/cdn-cgi/l/email-protection#1a73747c755a7773696e7f6837787673696e7f6834797577" target="_top" rel="noopener noreferrer"><span class="__cf_email__" data-cfemail="9df4f3fbf2ddf0f4eee9f8efb0fff1f4eee9f8efb3fef2f0">[email&#160;protected]
Phone: +38 044 593 3355
Office address: <a href="https://maps.app.goo.gl/Mex9ZmeWE4wrwcRF9?g_st=ic" target="_blank" rel="nofollow noopener">43 Chornovola Street, Vyshneve city, Kyiv region 08132, Ukraine

Fibrosis is a pathological condition in which thickening and compaction of tissue occurs, leading to dysfunction of organs. We will look at different forms of fibrosis, such as pulmonary fibrosis, cirrhosis of the liver, and cystic fibrosis. We will discuss the causes of fibrosis, its clinical manifestations, as well as modern methods of diagnosis and treatment of these diseases. Visitors to the site can learn how to manage symptoms and slow the progression of fibrosis.

Research data: Bristol-Myers Squibb has every chance of developing the first drug for treating progressive lung fibrosis.

Health, News, Pharmaceutical Business / Вікторія МАКАРЕНКО / 13.09.2023 / Fibrosis, Medical research, Medical technology

Bristol-Myers Squibb pharmaceutical company has reported the latest data from the second phase of the study of the oral antagonist of lysophosphatidic acid receptor 1 (LPA1) BMS-986278 in patients with progressive pulmonary fibrosis (PPF).

Research data: Bristol-Myers Squibb has every chance of developing the first drug for treating progressive lung fibrosis. Read More »